QLB After Nephrectomy

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

August 25, 2019

Conditions
Pain, PostoperativeChronic Postoperative Pain
Interventions
PROCEDURE

QLB

On the side of the surgery, QLB with 0.375% ropivacaine (0.2 mL/kg)

DEVICE

PCA

Patient-controlled analgesia

PROCEDURE

GA

General anesthesia

DRUG

Oxycodone

administered by PCA

DRUG

Sevoflurane

Inhalational anesthetic during GA

DRUG

Fentanyl

painkiller during GA

DRUG

Rocuronium

muscle relaxant during GA

Trial Locations (2)

15-950

Department of Anesthesiology and Intensive Care, J. Śniadecki Hospital in Białystok, Bialystok

35-055

Department of Anesthesiology and Intensive Care, F. Chopin Hospital in Rzeszów, Rzeszów

All Listed Sponsors
collaborator

Department of Anesthesiology and Intensive Care, F. Chopin Hospital in Rzeszów

UNKNOWN

collaborator

Department of Anesthesiology and Intensive Care, J. Śniadecki Hospital in Białystok

UNKNOWN

lead

Medical University of Lublin

OTHER

NCT03529201 - QLB After Nephrectomy | Biotech Hunter | Biotech Hunter